Positive Buy Rating for Upstream Bio Driven by Verekitug’s Potential in Severe Asthma and Expansion into CRSwNP and COPD Markets
Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...
Promising Market Impact: Yasmeen Rahimi’s Buy Rating on Upstream Bio’s Verekitug for Asthma and COPD
Yasmeen Rahimi, an analyst from Piper Sandler, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Yasmeen Rahimi has given her Buy ...
The Indian Express41m
Across Delhi hospitals, spike in patients with respiratory illnesses; elderly people & children worst hit
From visits to the emergency ward by the elderly due to breathing difficulties to a sudden spike in the number of patients affected by COPD (chronic obstructive pulmonary disease) and asthma, ...
Social isolation can take a deadly toll on older individuals with COPD, says study
University of California, San Francisco and the University of Alabama at Birmingham researchers have identified a link ...
manilatimes56m
Pulmonx to Present at the Stifel 2024 Healthcare Conference
REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx”) a global leader in ...
manilatimes57m
ResMed Announces Participation in the UBS Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global ...